Search

Your search keyword '"Ramer, Sarah"' showing total 37 results
Start Over Author "Ramer, Sarah"
37 results on '"Ramer, Sarah"'

2. Kidney Transplant Clinicians’ Perceptions of Palliative Care for Patients With Failing Allografts in the US: A Mixed Methods Study

Author

Murakami, Naoka, Reich, Amanda J., He, Katherine, Gelfand, Samantha L., Leiter, Richard E., Sciacca, Kate, Adler, Joel T., Lu, Emily, Ong, Song C., Concepcion, Beatrice P., Singh, Neeraj, Murad, Haris, Anand, Prince, Ramer, Sarah J., Dadhania, Darshana M., Lentine, Krista L., Lakin, Joshua R., and Alhamad, Tarek

Published
2024
Full Text
View/download PDF

4. 2023 CCS/CSE Standards for Physician Training and Maintenance of Competence in Adult Echocardiography: Executive Summary

Author

Nair, Parvathy, primary, Chen-Tournoux, Annabel, additional, Almufleh, Aws S., additional, Blissett, Sarah, additional, Ducas, Robin, additional, Fine, Nowell M., additional, Johri, Amer M., additional, Kushneriuk, Dominique, additional, Ramer, Sarah, additional, Sanfilippo, Anthony, additional, Thibodeau-Jarry, Nicolas, additional, Yu, Eric, additional, Bewick, David, additional, Burwash, Ian G., additional, Chow, Chi-Ming, additional, Cooley, Heather, additional, De, Sabe, additional, Douflé, Ghislaine, additional, Fagan, Susan M., additional, Henri, Christine, additional, Jassal, Davinder S., additional, Jelic, Tom, additional, Lee, Dana, additional, Leipsic, Jonathon, additional, Leong-Poi, Howard, additional, Luksun, Warren, additional, Mulloy, Andrew J., additional, Mulvagh, Sharon, additional, Nesbitt, Gillian, additional, Promislow, Steven, additional, Sebag, Igal A., additional, Tran, Diem T.T., additional, and Tsang, Teresa S.M., additional

Published
2023
Full Text
View/download PDF

6. Kidney Transplant Clinicians’ Perceptions of Palliative Care for Patients With Failing Allografts in the US: A Mixed Methods Study

Author

Murakami, Naoka, primary, Reich, Amanda J., additional, He, Katherine, additional, Gelfand, Samantha L., additional, Leiter, Richard E., additional, Sciacca, Kate, additional, Adler, Joel T., additional, Lu, Emily, additional, Ong, Song C., additional, Concepcion, Beatrice P., additional, Singh, Neeraj, additional, Murad, Haris, additional, Anand, Prince, additional, Ramer, Sarah J., additional, Dadhania, Darshana, additional, Lentine, Krista L., additional, Lakin, Joshua R., additional, and Alhamad, Tarek, additional

Published
2023
Full Text
View/download PDF

7. Evaluating Independent Echocardiography Interpretation Skills; A Novel Assessment Tool

Author

Almufleh, Aws, primary, Kushneriuk, Dominique, additional, Yu, Eric, additional, Johri, Amer, additional, Ducas, Robin, additional, Thibodeau-Jarry, Nicolas, additional, Ramer, Sarah, additional, De, Sabe, additional, Blissett, Sarah, additional, Yu, Clarissa, additional, Yu, Arianna, additional, Szeto, Kenneth, additional, Chen-tournoux, Annabel, additional, and Nair, Parvathy, additional

Published
2023
Full Text
View/download PDF

9. Implementation of a Longitudinal POCUS Curriculum in the Core Internal Medicine Residency Program at Dalhousie University

Author

Faiella, Whitney, primary, Tran, Allen, additional, Houston, Simon, additional, Miller, Ashley, additional, Gray, Chris, additional, Nelson, Alex, additional, Culligan, Brent, additional, MacIntyre, Ciorsti, additional, Styles, Kim, additional, Ramer, Sarah, additional, Haroon, Babar, additional, Balan, Marko, additional, Shetty, Nabha, additional, Epstein, Ian, additional, Short, Christine, additional, and Mulvagh, Sharon, additional

Published
2021
Full Text
View/download PDF

10. Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?

Author

Sharma, Abhinav, primary, Aziz, Haya, additional, Verma, Subodh, additional, Abramson, Beth L., additional, Choi, Richard, additional, Chua, Grace L., additional, Connelly, Kim A., additional, Honos, George, additional, Mancini, G.B. John, additional, Ramer, Sarah A., additional, Swiggum, Elizabeth, additional, Teoh, Hwee, additional, Zieroth, Shelley, additional, and Leiter, Lawrence A., additional

Published
2021
Full Text
View/download PDF

13. Blown Wide Open

Author

Pirzada, Ashar, primary, Mokhtar, Ahmed T., additional, Stewart, Robbie, additional, Styles, Kim, additional, and Ramer, Sarah, additional

Published
2021
Full Text
View/download PDF

15. List of Contributors

Author

Afezolli, Debora, Anderson, Elizabeth B., Ankuda, Claire K., Arnold, Robert M., Aslakson, Rebecca A., Avant, Leslie C., Bakitas, Marie A., Baracos, Vickie E., Bates, Nicole E., Bedi, Bishen Singh, Bharani, Anup, Bhatia, Sonica, Biewald, Mollie A., Bogetz, Jori F., Boss, Renee, Childers, Julie W., Chilsen, Abigail, Chochinov, Harvey M., Choi, Eugene W., Christensen, Spencer, Chui, Derek W., Cooper, Zara, Cox, Christopher E., Currow, David C., Randall Curtis, J., Davis, Mellar P., Davison, Sara N., De Cherrie, Linda V., Dellon, Elisabeth P., Dharmarajan, Kavita V., Dhawale, Tejaswini M., Di Biase, Jennifer, Nicholas Dionne-Odom, J., Dow, Lindsay A., Downer, Kendall, El-Jawahri, Areej, Feder, Shelli L., Feraco, Angela M., Ferreira, Diana H., Flemig, David, Frydman, Julia L., Gelfman, Laura P., Goldhirsch, Suzanne L., Goldstein, Nathan E., Goreshnik, Ashley H., Gray, Tamryn F., George Handzo, The Reverend, Hanson, Tess R., Hirst, Jeremy M., Ho, J. Janet, Horton, Jay R., Huber, Michael T., Hume, Anne L., Hunsberger, Joann B., Hutchinson, Rebecca N., Irwin, Scott A., Iyer, Anand S., Javier, Noelle Marie C., Jobson, Meghan, Jones, Katie Fitzgerald, Jordan, Allison E., Kamal, Arif H., Kamdar, Mihir M., Kavalieratos, Dio, Kelley, Amy S., Kestenbaum, Allison R., Kezar, Carolyn E., Kiser, Stephanie B., Ko, Fred C., Kochan, Michael, Koncicki, Holly, Kotwal, Ashwin A., Krishnasamy, Priya, Lage, Daniel E., Lee, Sei, Lemmon, Monica E., Levine, Stacie K., Li, Lingsheng, Lilley, Elizabeth J., Lindenberger, Elizabeth, Lugassy, Mara, Lustbader, Dana, Marcewicz, Lawson J., Mather, Harriet L., Mc Pherson, Mary Lynn, Mehta, Ankita, Merlin, Jessica S., Meyerson, Rabbi Edith M., Mims, Lauren W., Morphew, Jared, Sean Morrison, R., Mulholland, Christie, Phillips, Erin O'Kelly, O'Neill, Lynn B., Odejide, Oreofe O., Ornstein, Katherine, Orth, Jessica, Pantilat, Steven Z., Partain, Daniel K., Patel, Arpan A., Pedowitz, Elizabeth, Pelleg, Ayla, Petrillo, Laura A., Porter-Williamson, Karin B., Qureshi, Saleem, Rabow, Michael W., Ragsdale, Lindsay, Rakoski, Mina, Ramer, Sarah J., Reckrey, Jennifer M., Reid, Thomas T., Reynolds, Rabbi Mackenzie Zev, Rhee, Charles L., Ritchie, Christine S., Rivera, Veronica, Robinson, Jacob E., Rosenberg, Abby R., Sacks, Sandra H., Samaan, Mena, Samsel, Chase B., Sanon, Martine, Scally, Christopher P., Scarborough, Bethann, Schenker, Yael, Shega, Joseph W., Silverman, Ethan J., Sinclair, Christian T., Smith, Alexander K., Smith, Cardinale B., Smith, Thomas J., Spitzer, J. Lee, Spragens, Lynn Hill, Stec, Robin K., Stockdill, Macy L., Suwanabol, Pasithorn A., Swetz, Keith Mark, Tatum, Paul, Tay, Djin L., Temel, Jennifer S., Thorvilson, Megan, Trachsel, Manuel, Treat, Lauren, Tucker, Rodney O., Tun, Sandy, Ufere, Nneka N., Unroe, Kathleen T., Verma, Manisha, Wagner, Courtney J., Waldrop, Deborah P., Wallingford, Gregory, Walter, Jennifer K., Warraich, Haider J., Weaver, Meaghann S., Webb, Jason A., Wells, Rachel, Wendlandt, Blair, Widera, Eric, Wood, Gordon J., Woodrell, Christopher D., Wright, Alexi A., Yang, Holly, Yerramilli, Divya, Zapata, Carly Benner, Zeng, Yvette S., and Zhang, Meng

Published
2023
Full Text
View/download PDF

24. Patient reactions to witnessed medical events in the dialysis center or to the sudden absence of other patients from the center: A qualitative study.

Author

Ramer, Sarah J., Reid, M. Carrington, and Unruh, Mark L.

Subjects
*HEMODIALYSIS facilities, *PATIENTS' attitudes, *QUALITATIVE research, *SEMI-structured interviews
Abstract

Introduction: Patients receiving in‐center maintenance hemodialysis (HD) spend a significant amount of time together. To date, little or no research has examined how these patients perceive and process other patients' medical events in and absences from their centers. We therefore undertook this qualitative study using semi‐structured interviews to explore these phenomena from the patient perspective. Methods: Patients at a suburban Pittsburgh HD center participated in semi‐structured interviews in April to May 2011, reporting on their impressions of their relationships with other patients in the center; their experiences of witnessing clinical decompensations in the center; and their reactions to absences of fellow patients from the center. Trained coders developed a codebook and applied it to interview transcripts. Findings: There were 17 participants, 47% women, 29% black, with median age 63 years. Almost every participant had witnessed other patients' medical events during HD. Three main themes emerged in analysis of interviews: (1) incomplete knowledge of many aspects of witnessed events and patient absences in the HD center; (2) a process of "filling in the blanks": Participants used their own past events and absences to help process other patients' events and absences and used other patients' events and absences to help process their own future events and absences; and (3) participants' broad support for HD center staff being able to share with other patients basic information about their whereabouts if they themselves are absent from the center. Discussion: Witnessed medical events in and patients' absences from the HD center are not only common but are also important to patients, who struggle to process these events and absences due to limited information about what actually happened. Interventions, such as providing patients with more information, could improve patients' experience of witnessed events and fellow patients' absences and potentially impact other patient‐centered outcomes. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

26. Health Outcome Priorities of Older Adults with Advanced CKD and Concordance with Their Nephrology Providers’ Perceptions

Author

Ramer, Sarah J., primary, McCall, Natalie N., additional, Robinson-Cohen, Cassianne, additional, Siew, Edward D., additional, Salat, Huzaifah, additional, Bian, Aihua, additional, Stewart, Thomas G., additional, El-Sourady, Maie H., additional, Karlekar, Mohana, additional, Lipworth, Loren, additional, Ikizler, T. Alp, additional, and Abdel-Kader, Khaled, additional

Published
2018
Full Text
View/download PDF

27. It's More Than the Economy, Stupid: A tough job market is being made even tougher by technology that turns applicants into bits and bytes

Author

Ramer, Sarah

Subjects
Job hunting -- Personal narratives -- Analysis, Labor market -- Analysis -- Personal narratives, United States economic conditions -- Analysis -- Personal narratives, General interest, News, opinion and commentary, Analysis, Personal narratives
Abstract

Byline: Sarah Ramer One day during my senior year in college, as I obsessed about my future, my favorite professor attempted to cheer me up with what she claimed was [...]

Published
2003

32. THE ZOLOFT DEFENSE; Put mental health care system on trial

Author

Ramer, Sarah

Subjects
United States. Food and Drug Administration, General interest, News, opinion and commentary
Abstract

WITH THE FAILURE of the 'Zoloft defense' to clear a 15-year-old South Carolina boy of murder Tuesday, the controversy over giving antidepressant drugs to children has recaptured the public attention. [...]

Published
2005

35. Fission Yeast rad12+Regulates Cell Cycle Checkpoint Control and Is Homologous to the Bloom’s Syndrome Disease Gene

Author

Davey, Scott, Han, Christine S., Ramer, Sarah A., Klassen, Jennifer C., Jacobson, Adam, Eisenberger, Andrew, Hopkins, Kevin M., Lieberman, Howard B., and Freyer, Greg A.

Abstract

ABSTRACTThe human BLMgene is a member of the Escherichia coli recQhelicase family, which includes the Saccharomyces cerevisiae SGS1and human WRNgenes. Defects in BLMare responsible for the human disease Bloom’s syndrome, which is characterized in part by genomic instability and a high incidence of cancer. Here we describe the cloning ofrad12+, which is the fission yeast homolog ofBLMand is identical to the recently reportedrhq1+gene. We showed that rad12null cells are sensitive to DNA damage induced by UV light and γ radiation, as well as to the DNA synthesis inhibitor hydroxyurea. Overexpression of the wild-type rad12+gene also leads to sensitivity to these agents and to defects associated with the loss of the S-phase and G2-phase checkpoint control. We showed genetically and biochemically thatrad12+acts upstream fromrad9+, one of the fission yeast G2checkpoint control genes, in regulating exit from the S-phase checkpoint. The physical chromosome segregation defects seen in rad12null cells combined with the checkpoint regulation defect seen in the rad12+overproducer implicate rad12+as a key coupler of chromosomal integrity with cell cycle progression.

Published
1998
Full Text
View/download PDF

36. Letters.

Author

Winslow, Marni, Miller, Katharine, Presutti, Richard, Pollack, Sarah, Dyszel, Bill, McGirr, Margaret, Deutsch, Thomas, Berg, Alan, Roseman, Derek, Belsky, Ira, Newman, Susan, Hoppin, Christopher J., Kwestel, Melanie, Altmaier, Paulette, Ramer, Sarah, Miller, Philip G., and Darvick, Debra

Subjects
*LETTERS to the editor, *DESIGN, *SPORTS for children, *TEENAGE suicide, *ANTIDEPRESSANTS
Abstract

Presents letters to the editor referencing articles and topics discussed in previous issues. Responses to several articles dedicated to design in the November 28, 2004 issue; Youth sports in America today; Concerns about prescribing antidepressants for children in the November 21, 2004 issue; Others.

Published
2004

37. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.

Author

Cox JL, Ramer SA, Lee DS, Humphries K, Pilote L, Svenson L, and Tu JV

Subjects
Adrenergic beta-Antagonists therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Canada, Cardiotonic Agents therapeutic use, Digoxin therapeutic use, Diuretics therapeutic use, Drug Utilization statistics & numerical data, Humans, Spironolactone therapeutic use, Heart Failure drug therapy
Abstract

Introduction: Congestive heart failure (CHF) is responsible for significant morbidity, mortality and health resource consumption. There have been major advances in the treatment of this condition over the past two decades, yet little information is currently available regarding the current status of CHF management in Canada., Objective: To describe the pharmacological management of patients hospitalized with CHF in five provinces: Alberta, British Columbia, Nova Scotia, Ontario and Quebec., Design and Methods: Administrative data sources were used to identify all consecutive patients hospitalized with a principal diagnosis of CHF and discharged alive in the provinces of Alberta, British Columbia, Quebec and Ontario. Rates of use of prespecified medications at 30 days after hospital discharge were obtained for patients 65 years of age and older by linkage of their hospital records with drug benefit plans in these provinces. For Nova Scotia, the disease-specific registry of the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study was used to obtain discharge medications of individuals consecutively hospitalized with a diagnosis of CHF. Where available, data were acquired from 1997 to 2002., Results: Data were obtained for a total of 115,037 patients in the five provinces over the five-year period. Overall, 54.9% of patients received an angiotensin-converting enzyme inhibitor at or 30 days after hospital discharge, with minimal change in prescription rates over the five-year period. Beta-blocker prescription rates increased steadily during the study, more than doubling from 15.0% in 1997/1998 to 32.0% in 2001/2002. Spironolactone use increased dramatically, with only 2.2% of patients receiving this medication in 1997/1998 compared with 18.7% in 2001/2002. The rates of digoxin prescription decreased each year, while the use of angiotensin receptor blockers increased slightly throughout the observation period., Conclusions: While the use of evidence-based treatment for CHF in Canada is increasing and is currently at levels similar to those reported in other developed countries, there is still the potential in every province for further improvement.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results